PATENT CLAIM ANALYSIS

Application Number: 15889714
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "373000"]

Abstract:
Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.

Claim (Index 5):
The method of  claim 4 , wherein the level of eosinophils is selected from the group consisting of at or above 100 cells per microliter, at or above 150 cells per microliter, at or above 200 cells per microliter, and at or above 300 cells per microliter.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.13793
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14912015', '15675912', '15461131', '15181526', '13966229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8648521160588681
- 35 USC 102 Novelty (BERT): 0.5663835220235931
- Combined Prediction Score: 0.8350052566553406
- Mean Citation Score: 483.247764
- Max Citation Score: 514.1058
- Similarity Product: 349.172842086196

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test